ENO1 and cancer: ENO1, a glycolytic enzyme acting as aplasminogen receptor on cellsurfaces, contributes to cancer cell proliferation, migration, invasion,and metastasis.194 ENO1 overexpressionhas been documented in a broad range of cancers including lung, breast,liver, and others and is usually associated with poor prognosis.